网站主页 >> CAS数据库列表 >> N-[4-氯-2-[(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)甲基]苯基]-2-羟基苯甲酰胺
N-[4-氯-2-[(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)甲基]苯基]-2-羟基苯甲酰胺
|
|
- CAS号:
- 693288-97-0
- 英文名:
- N-{4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide
- 英文别名:
- CPPHA;N-[4-Chloro-2-(phthalimidomethyl)phenyl]salicylamide;N-[4-chloro-2-[(1,3-dioxoisoindol-2-yl)methyl]phenyl]-2-hydroxybenzamide;N-[4-Chloro-2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]phenyl]-2-hydroxybenzamide;N-{4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide;Benzamide, N-[4-chloro-2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]phenyl]-2-hydroxy-
- 中文名:
- N-[4-氯-2-[(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)甲基]苯基]-2-羟基苯甲酰胺
- 中文别名:
- 化合物 T10881;CPPHA,MGLU1和MGLU5受体的正变构调节剂;N-[4-氯-2-[(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)甲基]苯基]-2-羟基苯甲酰胺
- CBNumber:
- CB02538813
- 分子式:
- C22H15ClN2O4
- 分子量:
- 406.82
- MOL File:
- 693288-97-0.mol
|
|
|
N-[4-氯-2-[(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)甲基]苯基]-2-羟基苯甲酰胺化学性质
-
沸点:
-
539.7±50.0 °C(Predicted)
-
|
-
密度:
-
1.505
-
|
-
储存条件:
-
-20°C
-
|
-
溶解度:
-
DMSO: >20mg/mL
-
|
-
形态:
-
solid
-
|
-
酸度系数(pKa):
-
8.24±0.30(Predicted)
-
|
N-[4-氯-2-[(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)甲基]苯基]-2-羟基苯甲酰胺性质、用途与生产工艺
CPPHA 是一种高效、选择性的代谢型谷氨酸受体 mGluR5 和 mGluR1 正向变构调制器 (PAM)。CPPHA 可增强 mGluR5 和 mGluR1 对受体激活的反应。CPPHA 被开发用于中枢神经系统疾病的研究。
CPPHA alone has no agonist activity.
CPPHA causes concentration-dependent potentiation of the response of human mGluR5 CHO cells to agonists.
CPPHA potentiates threshold response to glutamate in fluorometric Ca
2+
assays 7- to 8-fold with EC
50
values in the 400 to 800 nM range.
CPPHA (20 μM; 15 minutes) potentiates the response to a subthreshold concentration of DHPG (HY-12598A) on ERK and cyclic-AMP responsive element-binding protein (CREB) activity, as well as NMDA receptor subunit NR1 phosphorylation in cortical and hippocampal slices.
Western Blot Analysis
Cell Line:
|
Rat hippocampal cells
|
Concentration:
|
20 μM
|
Incubation Time:
|
15 minutes
|
Result:
|
Potentiated the DHPG (20 μM)-induced increase in phosphorylation of ERK and CREB, approaching levels seen with 100 μM DHPG alone.
|
N-[4-氯-2-[(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)甲基]苯基]-2-羟基苯甲酰胺
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/04/30 | HY-14612 | N-[4-氯-2-[(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)甲基]苯基]-2-羟基苯甲酰胺 CPPHA | 693288-97-0 | 10mM * 1mLin DMSO | 770元 |
2024/04/30 | HY-14612 | N-[4-氯-2-[(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)甲基]苯基]-2-羟基苯甲酰胺 CPPHA | 693288-97-0 | 10mg | 1300元 |
N-[4-氯-2-[(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)甲基]苯基]-2-羟基苯甲酰胺
生产厂家
693288-97-0, N-[4-氯-2-[(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)甲基]苯基]-2-羟基苯甲酰胺 相关搜索:
- 合成有机化合物配体
- G蛋白偶联受体&G蛋白
- CPPHA,MGLU1和MGLU5受体的正变构调节剂
- 化合物 T10881
- N-[4-氯-2-[(1,3-二氢-1,3-二氧代-2H-异吲哚-2-基)甲基]苯基]-2-羟基苯甲酰胺
- 693288-97-0
- Benzamide, N-[4-chloro-2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]phenyl]-2-hydroxy-
- N-[4-chloro-2-[(1,3-dioxoisoindol-2-yl)methyl]phenyl]-2-hydroxybenzamide
- CPPHA
- N-[4-Chloro-2-(phthalimidomethyl)phenyl]salicylamide
- N-[4-Chloro-2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]phenyl]-2-hydroxybenzamide
- N-{4-chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide